Official publication of Rawalpindi Medical University
Gender Disparity In COVID-19: Clinicopathological Outcomes Among a Subset Of Karachi Population

Supplementary Files

PDF

How to Cite

1.
Attique H, Baig S, Kumar A, Mushtaq S, Jawad N. Gender Disparity In COVID-19: Clinicopathological Outcomes Among a Subset Of Karachi Population . JRMC [Internet]. 2025 Sep. 29 [cited 2025 Oct. 30];29(3). Available from: https://www.journalrmc.com/index.php/JRMC/article/view/2768

Abstract

Objective: In COVID-19, sex differences are increasing globally, and gender-specific mortality risk for men compared to women has been observed by researchers. This study aimed to explore clinic-pathological characteristics and the sex-related factors that might be the cause of gender disparity in COVID-19 cases.

Methods: A retrospective, observational cohort study was conducted at Ziauddin Hospital, Clifton, Karachi, from April to July 2020. Data were collected from the medical records of the admitted patients aged 18 and above, who tested positive for COVID-19 through the laboratory and had confirmed signs of pneumonia.

Results: Patients (244) were selected, including 167 (68.4%) males (mean ages 56.72±13.31) and 77 (31.6%) females (mean ages 56.36±17.15). The majority of the patients (87, 35.7%) had significant COVID-19 symptoms between 5 and 10 days. Only 4.4% of pregnant females had COVID-19 symptoms. Comorbidities included hypertension [44(18%)], diabetes mellitus [27(11.1%)], both HTN and DM60 [(24.6%)], whereas, 67(27.5%) patients had no known co-morbid. Complications were significantly more pronounced in males (p<0.001). Combined hypertension and diabetes observed a two-fold increase [36(14.8%)] in males than females [24(9.8%)]. Among these severely ill patients, 49 (20%) expired, which included 36 (14.3%) males and 13(5.2%) females, with statistically significant (p<0.05) results.

Conclusion: Our study found that men remained symptomatic for a longer duration (10-14 days) than women. Similarly, the severity of the disease, the complications, and the death rates were much higher in comorbid men than women. Females are genetically different and less exposed to environmental insults therefore we recommend that sex and gender-sensitive medicine (SGSM) may be added as a part of medical education.

https://doi.org/10.37939/jrmc.v29i3.2768

References

Dudley JP, Lee NT. Disparities in age-specific morbidity and mortality from SARS-CoV-2 in China and the Republic of Korea. Clinical Infectious Diseases. 2020 Mar 31;71(15):863-5. https://doi.org/10.1093/cid/ciaa354

Karlberg J, Chong DS, Lai WY. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? American journal of epidemiology. 2004 Feb 1;159(3):229-31. https://doi.org/10.1093/aje/kwh056

Fischer J, Jung N, Robinson N, Lehmann C. Sex differences in immune responses to infectious diseases. Infection. 2015 Aug;43:399-403. https://doi.org/10.1007/s15010-015-0791-9

Li Y, Jerkic M, Slutsky AS, Zhang H. Molecular mechanisms of sex bias differences in COVID-19 mortality. Critical care. 2020 Dec;24:1-6. https://doi.org/10.1186/s13054-020-03118-8

Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. The Journal of Immunology. 2017 May 15;198(10):4046-53. https://doi.org/10.4049/jimmunol.1601896

Galbadage T, Peterson BM, Awada J, Buck AS, Ramirez DA, Wilson J, Gunasekera RS. Systematic review and meta-analysis of sex-specific COVID-19 clinical outcomes. Frontiers in medicine. 2020 Jun 23;7:348. https://doi.org/10.3389/fmed.2020.00348

Jun T, Nirenberg S, Weinberger T, Sharma N, Pujadas E, Cordon-Cardo C, Kovatch P, Huang KL. Analysis of sex-specific risk factors and clinical outcomes in COVID-19. Communications Medicine. 2021 Jun 30;1(1):3. https://doi.org/10.1038/s43856-021-00006-2

Baig S. Gender disparity in infections of the Hepatitis B virus. J Coll Physicians Surg Pak. 2009 Sep 1;19(9):598-600.

Ramírez-de-Arellano A, Gutiérrez-Franco J, Sierra-Diaz E, and Laura Pereira-Suárez A. The role of estradiol in the immune response against COVID-19. Hormones (Athens). 2021; 20(4): 657–667. https://doi.org/10.1007/s42000-021-00300-7

Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nature Reviews Immunology. 2020 Jul;20(7):442-7. https://doi.org/10.1038/s41577-020-0348-8

Adams RB. Gender equality in work and Covid-19 deaths. Covid Economics. 2020 May 11(16):23-60. https://dx.doi.org/10.2139/ssrn.3601651

Amato-Menker CJ, Hopen Q, Pettit A, Gandhi J, Hu G, Schafer R, Franko J. XX sex chromosome complement modulates immune responses to heat-killed Streptococcus pneumoniae immunization in a microbiome-dependent manner. Biol Sex Differ. 2024 Mar 14;15(1):21. https://doi.org/10.1186/s13293-024-00597-0.

Wei X, Xiao YT, Wang J, Chen R, Zhang W, Yang Y, Lv D, Qin C, Gu D, Zhang B, Chen W. Sex differences in severity and mortality among patients with COVID-19: evidence from pooled literature analysis and insights from integrated bioinformatic analysis. arXiv preprint arXiv:2003.13547. 2020 Mar 30.

https://doi.org/10.48550/arXiv.2003.13547

Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2015 Jan 1;109(1):9-15. https://doi.org/10.1093/trstmh/tru167

vom Steeg LG, Klein SL. SeXX matters in infectious disease pathogenesis. PLoS pathogens. 2016 Feb 18;12(2):e1005374. https://doi.org/10.1371/journal.ppat.1005374

Poulas K, Farsalinos K, Zanidis C. Activation of TLR7 and innate immunity as an efficient method against COVID-19 pandemic: imiquimod as a potential therapy. Frontiers in immunology. 2020 Jun 11;11:548689. https://doi.org/10.3389/fimmu.2020.01373

Fallerini C, Daga S, Mantovani S, Benetti E, Picchiotti N, Francisci D, Paciosi F, Schiaroli E, Baldassarri M, Fava F, Palmieri M. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study. elife. 2021 Mar 2;10:e67569. https://doi.org/10.7554/eLife.67569

Poulas K, Farsalinos K, Zanidis C. Activation of TLR7 and innate immunity as an efficient method against COVID-19 pandemic: imiquimod as a potential therapy. Frontiers in immunology. 2020 Jun 11;11:548689. https://doi.org/10.3389/fimmu.2020.01373

Sakkas LI, Bogdanos DP, Chikanza IC. Sex Bias in Systemic Sclerosis: from Clinical to Immunological Differences. Clin Rev Allergy Immunol. 2025 May 27;68(1):51. https://doi.org/10.1007/s12016-025-09062-1.

Migeon BR. Choosing the active X: the human version of X inactivation. Trends in Genetics. 2017 Dec 1;33(12):899-909. https://doi.org/10.1016/j.tig.2017.09.005

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 2020 Jul;75(7):1730-41. https://doi.org/10.1111/all.14238

Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, Yu X, Dong K. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ open diabetes research and care. 2020 Apr 1;8(1):e001343. https://doi.org/10.1136/bmjdrc-2020-001343

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 Mar 28;395(10229):1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine. 2020 Apr 30;382(18):1708-20. https://doi.org/10.1056/NEJMoa2002032

Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International journal of oral science. 2020 Feb 24;12(1):1-5. https://doi.org/10.1038/s41368-020-0074-x

Li Y, Jerkic M, Slutsky AS, Zhang H. Molecular mechanisms of sex bias differences in COVID-19 mortality. Critical care. 2020 Dec;24:1-6. https://doi.org/10.1186/s13054-020-03118-8

Wortmann L, Oertelt-Prigione S. New approaches and established models for scaling up sex-and gender-sensitive medicine teaching. npj Women's Health. 2025 Jun 20;3(1):1-9. https://doi.org/10.1038/s44294-025-00080-0

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright (c) 2025 Hira Attique, Saeeda Baig, Ashok Kumar, Shamim Mushtaq, Nadia Jawad